Vitura Health Ltd (ASX: VIT) Share Price and News

Price

$0.067

Movement

0.00 (0.0)

as at 13 Jun 10:24am (20 mins delayed)

52 Week Range

$0.058 - $0.135

 
1 Year Return

-29.47%

Vitura Health Ltd Chart and Price Data

2025
2025
2025
2025
$0.05
$0.10
$0.15
$0.05
$0.10
$0.15
$0.05
$0.10
$0.15
$0.05
$0.10
$0.15

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $44.37 million
P/E Ratio 20.30
Dividend Yield 0.00%
Shares Outstanding 662.25 million
Earnings per share 0.003
Dividend per share 0.01
Year To Date Return -18.29%
Earnings Yield 4.93%
Franking 100%
Share Price

$0.067

Day Change

0.00 (0.0)

52 Week Range

$0.058 - $0.135

Yesterday's Close

$0.067

Today's Open

$0.067

Days Range

$0.067 - $0.067

Volume

5,688

Avg. Volume (1 month)

307,730

Turnover

$381

as at 13 Jun 10:24am

  • Vitura Health Ltd (ASX: VIT)
    Latest News

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    How did ASX cannabis shares perform in FY22?

    Here's a look at the sector's performance in the financial year just gone.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    Remember when ASX cannabis shares were smoking hot? Where are they now?

    Newly legalised recreational and medicinal marijuana markets aren't getting the media hype they once did.

    Read more »

    Young adult male farmer standing smiling in his indoor greenhouse full of herbal cannabis plants at a cannabis cultivation facility
    Cannabis Shares

    How have ASX cannabis shares been performing so far in 2022?

    The sector has held its own during volatile times.

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Cannabis Shares

    This little-known ASX cannabis share has quietly gained 26% in a month to trade at all-time highs

    Why is this ASX cannabis share having such a stellar month?

    Read more »

    Five healthcare workers standing together and smiling.
    Healthcare Shares

    2 ASX healthcare shares bucking the trend to hit new highs on Friday

    These healthcare shares are on form on Friday

    Read more »

    A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
    Share Gainers

    These were the best-performing ASX cannabis shares in 2021

    Despite a mixed bag for cannabis shares, some ended the year on a high

    Read more »

    a medical person in white coat, gloves and protective eyewear uses tools and a test tube to put cannabis buds into the tube for research purposes.
    Share Gainers

    Why is the Cronos (ASX:CAU) share price soaring 45% today?

    We check the latest on the ASX medical cannabis company.

    Read more »

    A white cannabis leaf set against a green background with a graph going up, indicating a rising share price for ASX cannabis shares
    Cannabis Shares

    What's the outlook for ASX Cannabis shares in 2022?

    December has been a tricky month for ASX cannabis shares.

    Read more »

    A woman wearing a pink blouse and straw hat holds up a cannabis leaf with tall green cannabis plants in the background
    Cannabis Shares

    These were the top performing ASX cannabis shares in November

    It was a tough month for ASX cannabis shares but we've identified 3 diamonds in the rough.

    Read more »

    Falling cannabis asx share price represented by cannabis leaves on a declining line graph
    Share Market News

    What's going wrong for ASX cannabis shares lately?

    Why Aussie cannabis companies are worth watching right now...

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2023 $0.0100 100.00% Final 28 Sep 2023
    16 Sep 2022 $0.0100 100.00% Final 11 Oct 2022

    VIT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    10th Jun 2025 2025-06-10T08:34:56 Change in substantial holdingYesNo8:34am289k
    19th May 2025 2025-05-19T08:31:10 Flora JV acquires Heyday Medical ClinicYesNo8:31am4190k
    12th May 2025 2025-05-12T08:39:59 Q3 FY2025 business updateYesNo8:39am4190k
    23rd Apr 2025 2025-04-23T09:08:31 Change in substantial holdingYesNo9:08am3275k
    22nd Apr 2025 2025-04-22T16:41:06 Notification of cessation of securities - VITYesNo4:41pm413k
    10th Apr 2025 2025-04-10T16:12:51 Response to ASX Letter about Director TradingYesNo4:12pm5431k
    7th Mar 2025 2025-03-07T17:01:18 S&P DJI Announces March 2025 Quarterly RebalanceYesNo5:01pm8179k
    4th Mar 2025 2025-03-04T14:09:23 Change of Director's Interest NoticeYesNo2:09pm2596k
    28th Feb 2025 2025-02-28T10:10:52 Change of Director's Interest NoticeYesNo10:10am2598k
    28th Feb 2025 2025-02-28T10:01:37 Investor webinar and presentationYesNo10:01am264.7M

    About Vitura Health Ltd

    Vitura Health Ltd. operates as a medicinal cannabis company. It engages in product and brand development, outsourced manufacturing and distribution for Australia and target export markets. The company was founded on September 27, 2018 and is headquartered in Melbourne, Australia.

    VIT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    11 Jun 2025 $0.07 $0.00 0.00% 308,865 $0.07 $0.07 $0.07
    10 Jun 2025 $0.07 $0.00 0.00% 342,135 $0.07 $0.07 $0.07
    06 Jun 2025 $0.07 $0.00 0.00% 176,474 $0.07 $0.07 $0.07
    05 Jun 2025 $0.07 $0.00 0.00% 1,011,387 $0.07 $0.07 $0.07
    04 Jun 2025 $0.07 $0.00 0.00% 416,394 $0.07 $0.07 $0.07
    03 Jun 2025 $0.07 $0.00 0.00% 67,556 $0.07 $0.07 $0.07
    02 Jun 2025 $0.07 $0.00 0.00% 53,183 $0.07 $0.07 $0.07
    30 May 2025 $0.07 $0.00 0.00% 115,500 $0.07 $0.07 $0.07
    29 May 2025 $0.07 $0.00 0.00% 248,229 $0.07 $0.07 $0.07
    28 May 2025 $0.07 $0.00 0.00% 355,137 $0.07 $0.07 $0.07
    27 May 2025 $0.07 $0.00 0.00% 329,543 $0.07 $0.07 $0.07
    26 May 2025 $0.07 $0.00 0.00% 551,223 $0.07 $0.07 $0.07
    23 May 2025 $0.07 $0.00 0.00% 28,360 $0.07 $0.07 $0.07
    22 May 2025 $0.07 $0.00 0.00% 24,777 $0.07 $0.07 $0.07
    21 May 2025 $0.07 $0.00 0.00% 178,084 $0.07 $0.07 $0.07
    20 May 2025 $0.07 $0.00 0.00% 185,133 $0.07 $0.07 $0.07
    19 May 2025 $0.07 $0.00 0.00% 13,852 $0.07 $0.07 $0.07
    16 May 2025 $0.07 $0.00 0.00% 1,295,778 $0.07 $0.07 $0.07
    15 May 2025 $0.07 $0.00 0.00% 519,761 $0.07 $0.07 $0.07
    14 May 2025 $0.07 $0.00 0.00% 10,743 $0.07 $0.07 $0.07
    13 May 2025 $0.07 $-0.01 -13.61% 497,816 $0.07 $0.08 $0.07

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    04 Mar 2025 Gerard Fogarty Buy 332,000 $24,900
    On-market trade.
    27 Feb 2025 Rebecca Wilson Buy 228,000 $19,835
    On-market trade.
    26 Feb 2025 Robert Iervasi Buy 344,550 $29,631
    On-market trade.
    04 Sep 2024 Robert Iervasi Buy 179,200 $15,076
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Shane Francis Tanner Non-Executive Director Oct 2018
    Mr Tanner is an Executive and Director with a record over many years of operating in multiple industries and markets. Shane was formerly CFO of an ASX Top 25 company (Mayne Nickless Limited (ASX: MAY)), as well as the inaugural CEO of Symbion Health (formerly known as Mayne Nickless Diagnostic Services). He also played a role in the float of Optus Communications. Over the past 20 years, Shane has been involved with multiple successful IPOs (including Vitura in November 2019) and many large-scale mergers and acquisitions. He has served as either the Chair or Non-Executive Director on more than ten public company boards and many other private companies.
    Ms Rebecca Jayne Wilson Non-Executive Director Nov 2024
    Ms Wilson is a company director with private, ASX-listed and not for-profit organisations. She is currently the Non-Executive Chair of global healthcare technology company, Alcidion Limited (ASX: ALC), and Ai-enabled technology platform LBT Innovations (ASX: LBT), and a Non-Executive Director of ASX listed enterprise technology company Hansen Technologies (ASX: HSN), and not-for-profit Tomisich Foundation. In an executive career spanning 25 years, she held global leadership roles in marketing communication, brand positioning, investor relations, capital management, and corporate affairs. She has expertise in ESG, complex stakeholder communication, brand awareness, issues, crisis and risk management, transactions, and investor relations. She has experience leading companies in commercial activation phases working with CEOs as both an advisor and Non-Executive Director. Shes worked as a NED since 2017, including Committee representation on Remuneration and Nominations (including as Chair), M&A, ESG, and Audit and Risk.
    Mr Robert Iervasi Non-Executive ChairmanNon-Executive Director Feb 2024
    Mr Iervasi as the former Group CEO and Director of Asahi Beverages, Robert led a diversified consumer products / FMCG business with more than $5 billion in annual revenue and over 5,000 employees, including a manufacturing footprint. Prior to this, he served as the Group COO and CFO and General Counsel of Asahi for over eight years, managing Finance, Shared Business Services, Legal, Risk Strategy and Information Technology, as well Sales, Marketing, Supply Chain and Science and Innovation. Robert has successfully driven profitability and growth across multiple categories, brands and channels. In 2020, he identified and executed the acquisition by Asahi of Carlton & United Breweries. Robert brings experience and expertise in governance, finance, law, and innovation to Vitura.
    Mr Gerard Paul Fogarty Non-Executive Director Nov 2024
    Mr Fogarty is a non-executive director and CEO.His board and executive roles have a variety of sectors, including national security, industrial relations regulation, work health and safety regulation, compensation and rehabilitation regulation, medical research, human performance research and health insurance. His background spans entities, including statutory authorities, joint ventures, industry bodies, not-for-profits and advisory boards. He was most recently a CEO of a private health insurer.
    Mr Daniel Francis Birch Non-Executive Director Nov 2024
    Mr Birch has 20 years experience advising clients across a range of industries.
    Mr Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO Aug 2020
    -
    Mr Geoff Cockerill Chief Executive Officer Nov 2024
    -
    Geoff Cockerill Chief Executive Officer
    -
    Thomas Godfrey Howitt Chief Financial OfficerCompany SecretaryInterim CEO
    -
    Nicola M. Swarbrick Chief Operating Officer
    -
    Ryan Tattle Chief Revenue Officer
    -
    Stefan Schmidt Chief Technology Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Elizabeth Sarah Jansen <Stanford Investment Trust> 118,757,765 20.62%
    Guy Rothwell Headley 95,548,772 16.59%
    Cronos Global Holdings Inc. 55,176,065 9.58%
    Matua Hasyo Charlie Jansen <Whanau Family Trust> 44,117,428 7.66%
    NewSouthern Investment Holdings 1 Pty Ltd <NewSouthern Investment Trust 1> 21,000,000 3.65%
    NewSouthern Investment Holdings A Pty Ltd 18,441,007 3.20%
    Citicorp Nominees Pty Limited 13,225,910 2.31%
    HSBC Custody Nominees (Australia) Limited 11,284,879 1.96%
    Ashanna Pty Ltd 10,766,897 1.87%
    Melbourne Securities Corporation Limited <BV1 Fund A/C> 9,000,000 1.56%
    Stone Group Pty Ltd <Stone Children A/C> 6,377,765 1.11%
    UBS Nominees Pty Ltd 5,833,174 1.01%
    EJ Watson (Medical) Pty Ltd <The EJ Watson Med S/F A/C> 5,000,000 0.87%
    Jessimine Jansen 4,253,379 0.74%
    Hektares SG Holdings Pte Ltd 4,050,940 0.70%
    Daniel Francis Birch <BES A/C> 3,766,498 0.65%
    Craig Graeme Chapman <Nampac Discretionary A/C> 3,500,000 0.61%
    Ryan Tattle 3,451,189 0.60%
    Robert Charles Hussey 3,000,000 0.52%
    William David Copland and Susan Mary Copland David Copland Super fund A/C> 2,484,000 0.43%

    Profile

    since

    Note